S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS

• Krina Patel,
• Paula Rodríguez-Otero,
• Salomon Manier,
• Rachid Baz,
• Marc S. Raab,
• Michele Cavo,
• Natalie Callander,
• Luciano Costa,
• Philippe Moreau,
• Scott Solomon,
• Christine Chen,
• Noopur Raje,
• Christof Scheid,
• Michel Delforge,
• Jeremy Larsen,
• Thomas Pabst,
• Kenshi Suzuki,
• Anna Truppel-Hartmann,
• Zhihong Yang,
• Julia Piasecki,
• Jasper Felten,
• Andrea Caia,
• Mark Cook,
• Sergio Giralt,
• Maria-Victoria Mateos

Affiliations

Krina Patel

1 MD Anderson Cancer Center, University of Texas, Houston, TX, United States

Paula Rodríguez-Otero

2 Clínica Universidad de Navarra, Pamplona, Spain

Salomon Manier

3 Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France

Rachid Baz

4 Moffitt Cancer Center, Tampa, FL, United States

Marc S. Raab

5 Heidelberg University Hospital, Heidelberg, Germany

Michele Cavo

6 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology and the Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy

Natalie Callander

7 University of Wisconsin Carbone Cancer Center, Madison, WI, United States

Luciano Costa

8 University of Alabama at Birmingham, Birmingham, AL, United States

Philippe Moreau

9 University Hospital of Nantes, Nantes, France

Scott Solomon

10 Northside Hospital Cancer Institute, Atlanta, GA, United States

Christine Chen

11 Princess Margaret Hospital, Toronto, ON, Canada

Noopur Raje

12 Massachusetts General Hospital, Boston, MA, United States

Christof Scheid

13 University Hospital of Cologne, Cologne, Germany

Michel Delforge

14 Universitaire Ziekenhuizen Leuven, Leuven, Belgium

Jeremy Larsen

15 Mayo Clinic Arizona, Phoenix, AZ, United States

Thomas Pabst

16 University Hospital Inselspital and University of Bern, Bern, Switzerland

Kenshi Suzuki

17 Japanese Red Cross Medical Center, Tokyo, Japan

Anna Truppel-Hartmann

18 2seventy bio, Cambridge, MA, United States

Zhihong Yang

19 Bristol Myers Squibb, Princeton, NJ, United States

Julia Piasecki

19 Bristol Myers Squibb, Princeton, NJ, United States

Jasper Felten

19 Bristol Myers Squibb, Princeton, NJ, United States

Andrea Caia

19 Bristol Myers Squibb, Princeton, NJ, United States

Mark Cook

19 Bristol Myers Squibb, Princeton, NJ, United States

Sergio Giralt

21 Memorial Sloan Kettering Cancer Center, New York, NY, United States

Maria-Victoria Mateos

22 Hospital Clínico Universitario de Salamanca, Salamanca, Spain